The trial is designed to assess the tolerability, efficacy, and safety of two different dosages of the therapy.

This enables us to see better. In optic neuritis, your optic nerve gets inflamed that leads to blurring of vision. Optic neuritis is also called retrobulbar neuritis. Depending on how inflamed ...

OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...

Feeling like something is making your head spin right round? You may be suffering from vestibular neuritis, a condition that can not only cause dizziness but also trigger migraines. While it may ...

By Karen Roman Oculis Holding AG (Nasdaq: OCS) said Phase 2 of its neuroprotective candidate OCS-05 met key endpoints of ...

Ophthalmic diseases specialist Oculis Holding AG announced positive phase II data showing its serum-glucose corticoid ...

Oculis Holding ( (OCS) ) has issued an update. Oculis Holding has announced positive results from a Phase 2 trial for OCS-05, a potential first-in-class neuroprotective therapy for acute optic ...

Medically reviewed by David Ozeri, MDEarly signs of multiple sclerosis can include blurry vision, muscle weakness, dizziness and fatigue, and unusual tingling or pain sensations. These early warning ...

The trial met safety and efficacy endpoints. OCS-05 met safety and efficacy endpoints in the treatment of acute optic neuritis in a phase 2 trial, according to a press release from Oculis.

Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...

Oculis’ peptidomimetic small molecule has been shown to help protect the eyes of patients with inflammation of the optic ...

Optic neuritis is an inflammatory condition that commonly occurs early in the presentation of multiple sclerosis (MS). 1 In fact, optic neuritis is frequently the presenting symptom of MS, and ...